Delayed
Toronto S.E.
16:30:43 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
1.95
CAD
|
+8.33%
|
|
+10.17%
|
-19.09%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
527.9
|
290.4
|
245.1
|
266.8
|
200.3
|
-
|
-
|
Enterprise Value (EV)
1 |
527.9
|
290.4
|
206.5
|
266.8
|
226.1
|
336.7
|
200.3
|
P/E ratio
|
-87
x
|
-
|
-15.3
x
|
-8.03
x
|
-5.63
x
|
-6.14
x
|
-5.81
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
111
x
|
13.4
x
|
10.5
x
|
EV / Revenue
|
-
|
-
|
-
|
-
|
126
x
|
22.5
x
|
10.5
x
|
EV / EBITDA
|
-
|
-42.7
x
|
-14
x
|
-8.6
x
|
-6.93
x
|
-12.7
x
|
-9.11
x
|
EV / FCF
|
-
|
-36.8
x
|
-
|
-
|
-5.36
x
|
-2.16
x
|
-1.11
x
|
FCF Yield
|
-
|
-2.72%
|
-
|
-
|
-18.7%
|
-46.3%
|
-90.3%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
86,677
|
95,528
|
100,464
|
110,699
|
111,292
|
-
|
-
|
Reference price
2 |
6.090
|
3.040
|
2.440
|
2.410
|
1.800
|
1.800
|
1.800
|
Announcement Date
|
15/03/21
|
28/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
1.8
|
14.97
|
19
|
EBITDA
1 |
-
|
-6.804
|
-14.75
|
-31
|
-32.65
|
-26.43
|
-22
|
EBIT
1 |
-
|
-
|
-
|
-
|
-35.98
|
-32.32
|
-55.1
|
Operating Margin
|
-
|
-
|
-
|
-
|
-1,998.61%
|
-215.98%
|
-290%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-35.85
|
-25.75
|
-
|
Net income
1 |
-5.212
|
-
|
-15.82
|
-31.81
|
-36.98
|
-35.02
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-2,054.17%
|
-234.02%
|
-
|
EPS
2 |
-0.0700
|
-
|
-0.1600
|
-0.3000
|
-0.3200
|
-0.2933
|
-0.3100
|
Free Cash Flow
1 |
-
|
-7.898
|
-
|
-
|
-42.2
|
-156
|
-180.8
|
FCF margin
|
-
|
-
|
-
|
-
|
-2,344.44%
|
-1,042.32%
|
-951.58%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/03/21
|
28/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.025
|
0.1
|
0.625
|
-
|
EBITDA
1 |
-
|
-1.93
|
-
|
-4.932
|
-8.179
|
-7.554
|
-7.206
|
-8.209
|
-8.051
|
-7.976
|
-8.299
|
-8.473
|
-7.8
|
EBIT
1 |
-
|
-
|
-
|
-
|
-
|
-8.089
|
-7.582
|
-
|
-8.55
|
-9.25
|
-10.2
|
-10.25
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-37,000%
|
-10,200%
|
-1,640%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-7.688
|
-7.303
|
-
|
-7.95
|
-8.65
|
-9.6
|
-9.65
|
-
|
Net income
1 |
-
|
-
|
-2.003
|
-
|
-
|
-7.688
|
-7.303
|
-
|
-7.95
|
-8.65
|
-9.6
|
-9.65
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-34,600%
|
-9,600%
|
-1,544%
|
-
|
EPS
2 |
-
|
-
|
-0.0200
|
-0.0500
|
-0.0800
|
-0.0700
|
-0.0700
|
-
|
-0.0700
|
-0.0800
|
-0.0900
|
-0.0900
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/11/21
|
28/03/22
|
10/11/22
|
30/03/23
|
10/05/23
|
09/08/23
|
08/11/23
|
28/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
25.8
|
136
|
-
|
Net Cash position
1 |
-
|
-
|
38.7
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.7902
x
|
-5.16
x
|
-
|
Free Cash Flow
1 |
-
|
-7.9
|
-
|
-
|
-42.2
|
-156
|
-181
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
0.88
|
17.4
|
-
|
15.1
|
104
|
158
|
Capex / Sales
|
-
|
-
|
-
|
-
|
836.11%
|
692.54%
|
829.47%
|
Announcement Date
|
15/03/21
|
28/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Average target price
3.967
CAD Spread / Average Target +120.37% Consensus |
1st Jan change
|
Capi.
|
---|
| -19.09% | 146M | | +13.63% | 64.32B | | -3.80% | 45.95B | | +13.69% | 39.61B | | +20.84% | 25.74B | | +8.66% | 18.75B | | +0.19% | 17.23B | | -21.03% | 15.86B | | +0.86% | 15.03B | | -14.60% | 13.99B |
Other Specialty Chemicals
|